Terug
Dagbereik
€ 4,18
€ 4,35
52-Weeksbereik
€ 1,54
€ 9,75
Volume
2.587.732
50D / 200D Gem.
€ 5,51
/
€ 4,59
Vorige Slotkoers
€ 4,35
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -7,3 | 0,3 |
| P/B | 4,9 | 2,9 |
| ROE % | -53,2 | 3,7 |
| Net Margin % | -325,3 | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 12,40
+189.7%
Low: € 10,00
High: € 17,00
Forward WPA
-€ 0,48
Omzet Sch.
190 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 0,32
€ 0,26 – € 0,39
|
670 M | 2 |
| FY2029 |
€ 0,04
€ 0,03 – € 0,04
|
500 M | 4 |
| FY2028 |
-€ 0,12
-€ 0,30 – € 0,30
|
410 M | 6 |
Belangrijkste Punten
Debt/Equity of 0,03 — conservative balance sheet
Negative free cash flow of -173,78M
PEG of 0,21 suggests growth is underpriced
Capital efficient — spends only 0,56% of revenue on capex
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)698,96%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-53,18%
ROIC-50,59%
Net Margin-325,31%
Op. Margin-338,72%
Veiligheid
Debt / Equity
0,03
Current Ratio6,95
Interest Coverage-15,57
Waardering
P/E Ratio
-7,25
P/B Ratio4,85
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 698,96% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 62,90M | Net Income (TTM) | -204,63M |
| ROE | -53,18% | ROA | -34,40% |
| Gross Margin | 86,58% | Operating Margin | -338,72% |
| Net Margin | -325,31% | Free Cash Flow (TTM) | -173,78M |
| ROIC | -50,59% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,03 | Current Ratio | 6,95 |
| Interest Coverage | -15,57 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -7,25 | P/B Ratio | 4,85 |
| P/S Ratio | 23,58 | PEG Ratio | 0,21 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,48B | Enterprise Value | 1,33B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 62,90M | 7,87M | 0,0 | 0,0 | 0,0 |
| Net Income | -204,63M | -567,94M | -75,80M | -104,20M | -86,85M |
| EPS (Diluted) | -0,60 | -2,11 | -0,35 | -0,48 | -0,44 |
| Gross Profit | 54,46M | 795.000,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -213,06M | -592,63M | -99,82M | -119,73M | -93,32M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 594,82M | 540,63M | 621,48M | 672,14M | 776,15M |
| Total Liabilities | 289,11M | 76,84M | 16,36M | 17,07M | 30,15M |
| Shareholders' Equity | 305,72M | 463,79M | 605,12M | 655,08M | 746,00M |
| Total Debt | 10,15M | 8,92M | 4,01M | 4,26M | 3,06M |
| Cash & Equivalents | 164,09M | 35,72M | 42,65M | 101,10M | 132,42M |
| Current Assets | 571,52M | 526,26M | 616,43M | 667,32M | 772,07M |
| Current Liabilities | 82,23M | 58,24M | 13,97M | 13,16M | 16,93M |